GLUE
Monte Rosa Therapeutics, Inc. Common Stock ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Monte Rosa Therapeutics, Inc. Common Stock (GLUE) is held by 3 tracked hedge fund(s). Largest tracked holder: BAKER BROS. ADVISORS LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
0.4% | 4.3M | $71M | — | $6.13 | 2026-03-31 |
| Suvretta Capital Aaron Cowen |
1.8% | 4.2M | $70M | ▲ 26% (+867K) | $6.67 | 2026-03-31 |
| Alphabet Inc Alphabet Inc |
0.3% | 684K | $11M | ▼ 8.1% (−61K) | $7.79 | 2026-03-31 |
FAQ ▾
Which hedge funds hold GLUE?
Tracked holders include: BAKER BROS. ADVISORS LP, Suvretta Capital, Alphabet Inc.
How much smart money owns GLUE?
3 tracked hedge fund(s) have disclosed positions.
Are members of Congress trading GLUE?
No tracked Congressional trades in GLUE on file.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.